Jeff Yass’s ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share ATIP.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-13,067
Closed -$71 13954
2022
Q4
$71 Buy
+13,067
New +$593 ﹤0.01% 12242

Other funds holding ATIP.WS

Jeff Yass's ATIP.WS Position: Q1 2023 in Review

Jeff Yass sold out of ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (ATIP.WS) in Q1 2023, closing a stake of 13,067 shares — an estimated $71 sold.

Jeff Yass first reported a position in ATIP.WS in Q4 2022 and held it in 1 quarter. The position peaked at $71 in Q4 2022. 17 funds tracked by Wall St. Rank hold ATIP.WS as of Q1 2023.

  • Jeff Yass reported no remaining ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
  • Jeff Yass sold 13,067 ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q1 2023, an estimated $71.
  • Jeff Yass first reported a position in ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q4 2022 and held it in 1 quarter.
  • Jeff Yass's ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $71 in Q4 2022.
  • 17 funds tracked by Wall St. Rank held ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.